Male Infertility Market By Techniques ( DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Penetration Assay, Sperm Agglutination, Computer Assisted Semen Analysis and Others), By Treatment (Assisted Reproductive Technology, Medication), Industry Analysis, COVID-19 Impact Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2028

pa_user-types

Check Today's Best Price

$3500 Buy Now
The global Male Infertility market size is estimated at 5.46 billion USD with a CAGR of7.1% during the forecasted period from 2021-2028.
  • The global Male Infertility market size is estimated at 5.46 billion USD with a CAGR of7.1% during the forecasted period from 2021-2028.

    A medical disorder wherein a male’s reproductive system is affected. Such a condition majorly occurs due to low sperm count, sperm blockage abnormal sperm functioning. Consequently, there is a rise in male fertility all over the globe which is positively boosting the demand for diagnosis and treatment.

    The key factor driving the Male Infertility market is attributed to growing rate of infertility in males all over the globe. In addition, some of the other factors that significantly impact the market growth include increasing obesity, sedentary lifestyle, stress, excessive smoking, alcohol abuse, etc. Besides, there is a rise in various chronic diseases such as prostate cancer, testosterone deficiency, abnormal sperm functioning, etc. which contribute to male infertility.  Also, increasing demand for hormonal therapy, use of drugs, etc. is fostering the market growth.

    Correspondingly, there are initiatives taken by government in many countries to enhance reimbursement policies and stringent regulations for security of patient data is assessed to influence the market size.

    Moreover, increasing awareness among people along with innovations in diagnostic test is projected to create lucrative opportunities for this market during the forecast period. Furthermore, rise in research & development activities along with improved reproductive techniques is positively supporting the Male Infertility market. Likewise, increasing disposable income along with rise in medical tourism is anticipated to surge the market growth.

    On the other hand, one of the major factors that limits the Male Infertility market is high cost of procedures.

    Infertility is diagnosed when a couple who is unable to conceive, trying over the course of one year. When the problem lies with the male partner it is referred to as male infertility. Infertility is a widespread problem. A man’s fertility generally relies on the quantity and quality of his sperm. If the number of sperm a man ejaculates is low or if the sperm is of a poor quality, it will be difficult, and sometimes impossible, for him to cause pregnancy. For about one in five infertile couples, the problem lies solely in the male partner. It is estimated that approximately 7% of all men are infertile. The basic treatments involved in male infertility are surgery, treatment for problems in intercourse, hormone treatment, and ART technology.

    Male Infertility Market Dynamics

    Both the developed and developing nations are facing infertility issues as a result of improper lifestyle. Delayed pregnancy and aging are the major factors driving the global infertility cases. Moreover, advancement in the ART technology is a major issue which is pushing the market growth. However, negative impact generated due to repeated failures in treatment and social & cultural taboos can restrain the market growth. On the other hand, increased awareness level may lead to market growth.

    MALE INFERTILITY MARKET SEGMENTATION

    By Techniques

    • DNA Fragmentation Technique
    • Oxidative Stress Analysis
    • Microscopic Examination
    • Sperm Penetration Assay
    • Sperm Agglutination
    • Computer Assisted Semen Analysis
    • Others

    By Treatment

    • Assisted Reproductive Technology
    • Medication

    By Geography

    • North America
    • Europe
    • Asia Pacific
    • RoW

    keyboard_arrow_up
  • Table of Content

    keyboard_arrow_up
  • • EMD Serono, Inc.
    • Cadila Healthcare Ltd
    • ASKA Pharmaceuticals, Inc.
    • Intas Pharmaceuticals Ltd.
    • Pantarhei Bioscience B.V.
    • Cordex Pharma, In
    • Halotech DNA SL
    • SCSA Diagnostics, Inc.
    • Andrology solutions
    • Access Pharmaceuticals, Inc.

    keyboard_arrow_up


      • Keep your personal detail safe with us. Privacy Policy
        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    What Information does this report contain?

    • What was the market size of the Male Infertility Market in 2016 and the expected market size by 2024, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions, and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2016 – 2024)?
    • Which are the leading companies in the Male Infertility Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

    CLIENTS

    SHARE YOUR CART